Retinoblastoma Clinical Research
Only 10% of affected children live in developed countries, where most retinoblastoma clinical research takes place and the main focus is saving sight.
90% of affected children live in developing countries, where clinical research is difficult due to limited resource. Most of these children have advanced cancer and the priority is life-saving treatment and palliative care.
This makes it difficult to conduct rigorous clinical trials that effectively answer the key question.
Currently, retinoblastoma research benefits about 6% of children in the world with eye cancer. Collaborative global retinoblastoma clinical trials will improve care for many more children.